IP Library Granted Patent US 9,358,284
Granted Patent B2
US 9,358,284 · App. 14/343,351 · Granted Jun 7, 2016

Methods for making saccharide-protein glycoconjugates

Inventors: Allan James Saul (Chianti, IT); Francesca Micoli (Florence, IT)
Assignee: GlaxoSmithKline Biologicals SA
A61K39/385A61K39/02A61K39/0275A61K39/095A61K47/4833A61K47/48261C07K14/34C07K16/1285C07K16/44C08B37/0003C08B37/006C08B37/0063C08B37/0081A61K2039/6037C07K2317/734
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,358,284
App. No.
14/343,351
Granted
Jun 7, 2016
Kind
B2
Abstract

The invention provides a process for the reductive amination of a carbonyl group at the reducing terminus of a polysaccharide, wherein the reductive amination is carried out at a pH between 4 and 5. The invention also provides a process for preparing a conjugate of a polysaccharide and a carrier molecule, comprising the steps of: (a) coupling the polysaccharide to a linker, to form a polysaccharide-linker compound in which the free terminus of the linker is an ester group; and (b) reacting the ester group with a primary amine group in the carrier molecule, to form a polysaccharide-linker-carrier molecule conjugate in which the linker is coupled to the carrier molecule via an amide linkage. The invention also provides a process for reducing contamination of a polysaccharide-linker compound with unreacted linker, comprising a step of precipitating unreacted linker under aqueous conditions at a pH of less than 5.

Claims (30)

1. A process for the reductive amination of a carbonyl group at the reducing terminus of a polysaccharide, comprising:

combining the polysaccharide with a primary amine group in the presence of a reducing agent,

wherein the polysaccharide comprises:

a core domain from a lipopolysaccharide of a Gram-negative bacterium; and

a carbonyl group at the reducing terminus, and

reacting the carbonyl group with the primary amine group by reductive amination,

wherein the reductive amination is carried out at a pH between 4 and 5.

2. The process of claim 1 , wherein the carbonyl group is within a KDO subunit at the reducing terminus of the polysaccharide.

3. The process of claim 1 , wherein the reductive amination comprises reacting the carbonyl group with Y 1 in a bifunctional linker of the formula Y 1 -L-Y 2 , to form a polysaccharide-bifunctional linker compound in which the polysaccharide is coupled to the bifunctional linker via a C—N linkage, wherein:

Y 1 comprises a primary amine group that can react with the carbonyl group in the polysaccharide;

Y 2 comprises a second reactive group;

and L is a linking moiety.

4. The process of claim 3 , wherein the Y 1 and Y 2 are both —NHNH 2 groups.

5. The process of claim 4 , wherein L has formula -L′-L 2 -L′-, where L′ is carbonyl and L 2 is a straight chain alkyl with 1 to 10 carbon atoms.

6. The process of claim 4 , wherein L is carbonyl.

7. A process for preparing a conjugate of a polysaccharide and a carrier molecule comprising the steps of: (a) coupling the polysaccharide to a linker, to form a polysaccharide-linker compound in which the free terminus of the linker is an ester group; and (b) reacting the ester group with a primary amine group in the carrier molecule, to form a polysaccharide-linker-carrier molecule conjugate in which the linker is coupled to the carrier molecule via an amide linkage, further comprising precipitating unreacted linker under aqueous conditions at a pH of less than 5.

8. The process of claim 7 , wherein the linker has an ester group at both termini and the polysaccharide is coupled to the linker by reacting one of the ester groups with a primary amine group in the polysaccharide by nucleophilic acyl substitution, to form a polysaccharide-linker compound in which the polysaccharide is coupled to the linker via an amide linkage.

9. The process of claim 8 , wherein the linker is of the formula X 1 -L-X 2 , where X 1 is an ester group that can react with the primary amine group in the polysaccharide; X 2 is an ester group; and L is a linking moiety.

10. The process of claim 9 , wherein L is a straight chain alkyl with 1 to 10 carbon atoms.

11. The process of claim 9 , wherein X 1 -L-X 2 is adipic acid N-hydroxysuccinimide diester.

12. The process of claim 7 , wherein the polysaccharide comprises an additional linker, wherein the additional linker comprises a free terminus, and wherein step (a) comprises coupling the free terminus of the additional linker to the linker.

13. The process of claim 12 , wherein the additional linker has a primary amine group at both termini and the polysaccharide is coupled to the additional linker using a carbonyl group at the reducing terminus of the polysaccharide by a process comprising two steps:

(a 1 ) reacting the carbonyl group with one of the primary amine groups in the additional linker by reductive amination to form a polysaccharide-additional linker compound in which the polysaccharide is coupled to the additional linker via a C—N linkage; and

(a 2 ) reacting the free terminus of the additional linker with the linker.

14. The process of claim 7 , wherein the carrier molecule is CRM 197 diphtheria toxin mutant.

15. The process of claim 7 , wherein the precipitation takes place in an aqueous solution with a water content (vol/vol) of >60%.

16. The process of claim 7 , further comprising precipitating the polysaccharide-linker compound from solution with alcohol.

17. The process of claim 16 , wherein the alcohol is added to the solution containing the polysaccharide-linker compound to give a final concentration of ethanol or 2-propanol (vol/vol) between 80% and 95%.

18. The process of claim 17 , wherein the precipitated polysaccharide-linker compound is recovered by centrifugation.

19. The process of claim 7 , wherein the polysaccharide comprises a core domain from a lipopolysaccharide of a Gram-negative bacterium.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2016
From: NOVARTIS AG
To: GLAXOSMITHKLINE BIOLOGICALS SA
Reel/Frame 038982/0143 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 10, 2014
From: SAUL, ALLAN; MICOLI, FRANCESCA
To: NOVARTIS VACCINES INSTITUTE FOR GLOBAL HEALTH S.R.L.
Reel/Frame 032395/0243 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 10, 2014
From: NOVARTIS VACCINES INSTITUTE FOR GLOBAL HEALTH S.R.L.
To: NOVARTIS AG
Reel/Frame 032396/0890 →
Continuity (2)
Provisional Application 61534751 · Sep 14, 2011
Related Publication 20140329998A1 · Nov 6, 2014